Usefulness of Nutritional Assessment Indicators in Predicting Treatment Discontinuation Due to Adverse Events from PARP Inhibitors in Ovarian Cancer Patients
Our study suggested that PNI and mGPS can predict the risk of treatment discontinuation due to PARPi-related AEs before starting maintenance therapy. This insight opens avenues for more personalized treatment plans, potentially improving patient outcomes.
Authors
- Kenji Yashiro
- Yoshiaki Tanaka (ORCID: https://orcid.org/0000-0002-2078-9374)
- Kentaro Niwa
- Masataka Kato
- Yoshio Yoshida (ORCID: https://orcid.org/0000-0003-0769-0385)
- Makoto Orisaka (ORCID: https://orcid.org/0000-0002-1095-9579)
- Yuriko Nakamura (ORCID: https://orcid.org/0000-0003-4226-0655)
- Masato Kato (ORCID: https://orcid.org/0000-0001-8437-6248)
- Hideaki Tsuyoshi (ORCID: https://orcid.org/0000-0001-5765-5460)
- Daisuke Inoue (ORCID: https://orcid.org/0009-0005-5842-2147)
Institutions
- University of Fukui (JP)
- Fukui Prefectural Hospital (JP)
- Fukui Red Cross Hospital (JP)
- Ishikawa Prefectural Central Hospital (JP)
- Fukui-ken Saiseikai Hospital (JP)
- Saitama International Medical Center (JP)
Publication Details
- Journal
- Cancers
- Published
- 2024-10-25
- DOI
- https://doi.org/10.3390/cancers16213602
- Citations
- 2
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.57